Revue bibliographique 2025

Voici une recension la plus exhaustive possible* des articles (et parfois thèses) parus en 2025 :

PATHOGENIE

• BARRIERE CUTANEE
  • Combarros D, Brahmi R, Musaefendic E, et al. Reconstructed Epidermis Produced with Atopic Dog Keratinocytes Only Exhibit Skin Barrier Defects after the Addition of Proinflammatory and Allergic Cytokines. JID Innov 2025; 5: 100330. 20241126. DOI: 10.1016/j.xjidi.2024.100330.
• COMPORTEMENT, STRESS
  • Park GW, Ataallahi M and Park KH. Stress level in companion dogs with and without atopic dermatitis. J Anim Sci Technol 2025; 67: 468–476. 20250331. DOI: 10.5187/jast.2024.e28.
  • Génétique
    • Forman OP, Freyer J, Kerr A, et al. A splice donor variant in SLAMF1 is associated with canine atopic dermatitis. Frontiers in Vet Sci 2025; 12: 1550617.
• IgE
  • Gillepsie IN. Investigating Factors that Affect Total IgE Antibody Levels of a Canine Population in Louisville, KY. 2025.
• INFLAMMATION
  • Tamamoto-Mochizuki C and Mishra SK. Investigation of neutrophil infiltration in the acute canine atopic dermatitis model. Front Allergy 2025; 6: 1716716. 20251216. DOI: 10.3389/falgy.2025.1716716.
  • Chen B, Slocombe RF, Omotainse OS, et al. TNF- α and TH2 Cytokines Induced Canine Atopic Dermatitis–like Morphologic and Molecular Characteristics in the Canine Epidermal Organoid Culture System. Research Square 2025; preprint.
  • Banovic F and Blubaugh A. Epicutaneous house dust mite (HDM)-induced skin lesions feature early activation of T helper 2 inflammatory and pruritogenic pathways in HDM-nonsensitised dogs. Vet Dermatol 2025; 36: 392–400. 20241023. DOI: 10.1111/vde.13307.
  • Maina E, Devriendt B and Cox E. Exploring CD4 +CD8 + double-positive T cells in canine allergy and health: A pilot study. Vet Immunol Immunopathol 2025; 284: 110924. 20250402. DOI: 10.1016/j.vetimm.2025.110924.
• KERATINOCYTES
  • Santoro D, Archer L, Scotti G, et al. Intrinsic Alterations of the Inflammatory Pathways in Primary Canine Atopic Keratinocytes. Allergy 2025 20251017. DOI: 10.1111/all.70118.
• LIPIDOMIQUES
  • Fernandes B, Silva M, Alves SP, et al. Unlocking the potential of lipidomic analysis in canine atopic dermatitis research: Insights from a pilot study. Vet Dermatol 2025 20250612. DOI: 10.1111/vde.13363.
• MALASSEZIA
  • Dinkova V and Rusenova N. Prevalence of Malassezia pachydermatis yeasts in clinical infections in dogs: A single-center retrospective study at the University Veterinary Hospital, Stara Zagora, Bulgaria (2019-2023). Open Vet J 2025; 15: 4354–4361. 20250930. DOI: 10.5455/OVJ.2025.v15.i9.42.
• MICROBIOTE
  • Felten V, Turck JL, Unterer S, et al. An insight into the gut microbiota of healthy and allergic West Highland Whiter Terrier dogs. PLoS One 2025; 20: e0328100. 20250827. DOI: 10.1371/journal.pone.0328100.
  • Jahani HJ, Shahram; Yahyaraeyat, Ramak; Zahraei Salehi, Taghi; Boluki, Zahra; Ashrafi Tamai, Iradj. Cytological and Microbiological Study of the External Ear Canal in Dogs With Atopic Dermatitis. Iranian Journal of Veterinary Medicine 2025; 19: 635.
  • Gentry CM. Updates on the Pathogenesis of Canine Atopic Dermatitis and Feline Atopic Skin Syndrome: Part 2, the Skin Barrier, the Microbiome, and Immune System Dysfunction. Vet Clin North Am Small Anim Pract 2025; 55: 173–187. 20241227. DOI: 10.1016/j.cvsm.2024.11.002.
• PRURIT
  • Tamamoto-Mochizuki C and Mishra SK. Transcriptomic profiling of dorsal root ganglia in atopic and healthy dogs: A comparative RNA sequencing study with implications in cutaneous itch research. Vet Dermatol 2025 20250127. DOI: 10.1111/vde.13324.
  • Bell A, Nakamura Y, Langley R, et al. Staphylococcus pseudintermedius isolated from atopic dogs with pyoderma induces mast cell degranulation. N Z Vet J 2025: 1–11. 20250812. DOI: 10.1080/00480169.2025.2543031.
• STAPHYLOCOQUES
  • Szydlowski P, Grabowski T and Chelmonska-Soyta A. Tregitopes derived from canine proteins can enhance T regulatory lymphocytes frequency in dog peripheral blood mononuclear cells (PBMC) culture in vitro. J Leukoc Biol 2025; 117. DOI: 10.1093/jleuko/qiaf143.

EPIDEMIOLOGIE

• • Brem S, Antoine L, Maina E, et al. A vertical study on the prevalence and clinical symptoms of canine pruritic dermatoses in Switzerland. Schweiz Arch Tierheilkd 2025; 167: 33–43. DOI: 10.17236/sat00441.
  • Gonçalves NV, Costa de Oliveira DM, Soares NN, et al. Canine atopic dermatitis and its socioeconomic, environmental and public policy risk factors in Belém do Pará, Eastern Amazon, Brazil: a cross-sectional and ecological study. Semina Ciênc Agrár Londrina 2025; 46: 1733–1746.
  • Gentry CM. Updates on the Pathogenesis of Canine and Feline Atopic Dermatitis: Part 1, History, Breed Prevalence, Genetics, Allergens, and the Environment. Vet Clin North Am Small Anim Pract 2025; 55: 157–171. 20241227. DOI: 10.1016/j.cvsm.2024.11.001.            
  • POLLUTION
    • Song Y, Kim Y, Kim J, et al. Indoor endotoxin and house dust mite concentrations in the canine homologue of human atopic dermatitis. One Health 2025; 20: 101076. 20250516. DOI: 10.1016/j.onehlt.2025.101076.
    • Han J, Cha HW, Eom Y, et al. Heavy Metals as Key Environmental Aggravators in Atopic Dermatitis in Companion Dogs: A One Health Perspective. Allergy 2025 20251020. DOI: 10.1111/all.70117.
    • Marsella R. Environmental factors are responsible for the rise of atopic dermatitis in dogs: veterinarians should focus on modifiable influences. J Am Vet Med Assoc 2025: 1–9. 20250924. DOI: 10.2460/javma.25.06.0391.
    • Marsella R. Theories and mechanisms of environmental factors that cause allergies in dogs: veterinarian involvement in lifestyle choices to support long-term well-being. Am J Vet Res 2025: 1–10. 20251008. DOI: 10.2460/ajvr.25.07.0275.

ALLERGIES

• • Aliments
    • Udraite Vovk L and Mueller RS. Adverse Food Reactions in Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 2025. DOI: https://doi.org/10.1016/j.cvsm.2025.11.003.
    • Maina E and Cox E. Exploring the potential link between vegetable oil supplementation and adverse food reactions in dogs: a preliminary study. BMC Vet Res 2025; 21: 269. 20250414. DOI: 10.1186/s12917-025-04720-0.
  • Intradermoréactions, IgE, tests allergologiques
    • Petak A, Samuel Badulescu E, Aleksandrova S, et al. Use of Colorimetry for the Measurement of Intradermally Injected Histamine-Induced Erythema in Healthy Dogs: A Proof-of-Concept Study. Vet Sci 2025; 12 20250615. DOI: 10.3390/vetsci12060590.
    • Jang YS, Han JI, Lee ES, et al. Prevalence of Allergen-Specific IgE Positivity and Serum Immunoglobulin E Concentrations of Allergens in Dogs with Suspected Allergic Dermatitis Using the Multiple Allergen Simultaneous Test in South Korea. Vet Sci 2025; 12 20250608. DOI: 10.3390/vetsci12060563.
    • Cabre M, Solano-Gallego L, DeBoer D, et al. Serum Allergen-Specific Immunoglobulin E Response in Dogs With Moderate-To-Severe Leishmaniosis. Vet Dermatol 2025 20250818. DOI: 10.1111/vde.70020.
    • Ban-Cucerzan A, Obistioiu D, Imre K, et al. Serological Investigations on Environmental Allergens Triggering Allergic Dermatitis in Dogs from Western Romania. Vet Sci 2025; 12 20250405. DOI: 10.3390/vetsci12040337.
    • Fernandez-Lozano C, Mas-Fontao A, Auxilia ST, et al. Evaluation of a direct lymphocyte proliferation test for the diagnosis of canine food allergies with delayed reactions after oral food challenge. Vet Dermatol 2025 20241121. DOI: 10.1111/vde.13312.
    • Santoro D, Moura RA, McKenzie SR, et al. Equivalence in intradermal reactions to histamine and compound 48/80 in dogs before and after sedation with dexmedetomidine or a 1:20 combination of medetomidine and vatinoxan. Vet Dermatol 2025; 36: 43–51. 20241014. DOI: 10.1111/vde.13306.
  • Régimes d’éviction   
    • Lewis TP, 2nd, Moore GE, Laporte C, et al. Evaluation of hydrolyzed salmon and hydrolyzed poultry feather diets in restrictive diet trials for diagnosis of food allergies in pruritic dogs. Front Vet Sci 2025; 12: 1560806. 20250508. DOI: 10.3389/fvets.2025.1560806.

BIOLOGIE DIVERSE

• • • Rohayu S, Suartha IN and Jayanti PD. Albumin and total protein levels in dogs with atopic dermatitis after treatment with coconut oil and diphenhydramine Bul Vet Udayana 2025; 17: 1577–1584.
    • Frizzo-Ramos C, Doulidis PG, Burgener IA, et al. Lymph food to improve canine atopic dermatitis: a randomized, double-blinded, controlled trial in dogs with standard-care treatment. Front Vet Sci 2025; 12: 1657869. 20251219. DOI: 10.3389/fvets.2025.1657869.

CLINIQUE

• • Comorbidités
    • Utzmann M, Bettenay S, Mueller RS, et al. Clinical Signs and Treatment Responses of 24 Dogs With Split Paw Pad Dermatosis. Vet Dermatol 2025 20250806. DOI: 10.1111/vde.70007.
    • Fang A, Kumar L, Creevy KE, et al. Constructing the first comorbidity networks in companion dogs in the Dog Aging Project. PLoS Comput Biol 2025; 21: e1012728. 20250814. DOI: 10.1371/journal.pcbi.1012728.
  • Sémiologie / diagnostic
    • Ryu JH, Kang JH, Kang YH, et al. Prevalence and lesion distribution of atopic dermatitis in small-to-medium breed dogs in Korea. Vet Dermatol 2025 20250212. DOI: 10.1111/vde.13329.
    • Langon X, Montoya M and Gourdon I. Machine Learning Model for an App-Based Tool to Assist With the Diagnosis of Canine Atopic Dermatitis. Vet Dermatol 2025 20250929. DOI: 10.1111/vde.70031.
    • Cugmas B and Štruc E. Effect of color calibration in a smartphone mHealth app for skin erythema monitoring. SPIE, 2025.
  • Cytologie
    • Atanasio NR, Ledur GR, Filho DM, et al. Use of a Cytobrush for Sampling the Ear Canal of Dogs With Otitis Externa. Vet Dermatol 2025 20251110. DOI: 10.1111/vde.70036.
    • T. Kovač* NL, N. Puvača and L. Medven Zagradišnik. Cytological Characteristics of the Eye Conjunctiva in Dogs with Atopic Dermatitis. Veterinarska Stanica 2025; 56: 339–348.
• TRAITEMENT
  • Prurit
    • O'Rourke A, Redford L, Carson A, et al. Retrospective observational study shows accelerometers can monitor effects of canine pruritus treatment. Am J Vet Res 2025; 86 20250122. DOI: 10.2460/ajvr.24.09.0269.
  • Alimentation et compléments alimentaires
    • Swain S, Sahoo P, Biswal S, et al. Fecal bacterial microbiota diversity characterized for dogs with atopic dermatitis: its alteration and clinical recovery after meat-exclusion diet. Am J Vet Res 2025; 86 20250207. DOI: 10.2460/ajvr.24.09.0274.
    • Rios-Carlos M, Jimenez M, Cervantes-Garcia D, et al. Immunomodulatory and anti-inflammatory effects of agave fructans in atopic dermatitis: gut microbiota and short-chain fatty acid implication. Front Immunol 2025; 16: 1700023. 20251202. DOI: 10.3389/fimmu.2025.1700023.
    • Park MK, Hong J, Cho WJ, et al. Clinical evaluation of a functional diet containing Siraitia grosvenorii residual extract for atopic dermatitis in dogs: a self-controlled study. BMC Vet Res 2025; 21: 645. 20251105. DOI: 10.1186/s12917-025-05055-6.
    • Shin HY, Shin SH, Shin HS, et al. Oral treatment with Rosa multiflora fructus extract modulates mast cells in canine atopic dermatitis. Front Vet Sci 2025; 12: 1531313. 20250409. DOI: 10.3389/fvets.2025.1531313.
    • Shah HJ and Jacky K Pariyani KVS, Bhakti A Dave and Priyal B Dakhore. Evaluation of the efficacy and Safety of Palmitoylethanolamide (PEA) combination in managing dermatitis in dogs. International Journal of Veterinary Sciences and Animal Husbandry 2025; 10: 219–225.
    • Watson A, Laxalde J, Martini F, et al. Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6-Month Randomised, Blinded, Controlled, Clinical Trial. Vet Dermatol 2025 20250811. DOI: 10.1111/vde.70017.
    • Guilherme-Fernandes J, Barroso C, Correia A, et al. Unraveling the role of shrimp hydrolysate as a food supplement in the immune function and fecal microbiota of beagle dogs. Sci Rep 2025; 15: 25510. 20250715. DOI: 10.1038/s41598-025-09942-8.
    • Ober LR, Larsen JA, Hoffman LE, et al. Analysis of selected nutrients and contaminants in fish oil supplements for dogs. Top Companion Anim Med 2025; 65: 100949. 20250106. DOI: 10.1016/j.tcam.2025.100949.
    • Eisenschenk MNC. The Role of Diet, Nutrition, and Supplements in Canine Atopic Dermatitis. Veterinary Clinics: Small Animal Practice 2025. DOI: 10.1016/j.cvsm.2024.11.003.
  • pARNi
    • Tang QHHF, et al. A Therapeutic Small-Interfering RNA Potentiates Janus Kinase 1 Modulation for the Treatment of Dog Inflammatory Diseases. ACS Pharmacol Transl Sci 2025.
  • Bleu de méthylène
    • Ural K, Erdogan H, Erdogan S, et al. Nebulized Methylene Blue as an Anti-Pruritic Treatment Modality in Dogs with Atopic Dermatitis. Bozok Vet Sci 2025; 6: 41–45. DOI: 10.58833/bozokvetsci.1704617.
  • Cellules souche
    • 김민수. Regenerative and immunomodulatory effects of canine amniotic membrane-derived mesenchymal stem cells in short- and long-term atopic dermatitis. 서울대학교 대학원, 2025.
  • Chlorhexidine
    • Matsuda A, Nakamura Y, Itoi T, et al. Daily topical application of chlorhexidine gluconate to the skin in dogs and its impact on skin barriers and cytotoxicity. J Vet Med Sci 2025 20250116. DOI: 10.1292/jvms.24-0311.
  • Cryothérapie
    • Han JI, Yoo D, Kim E, et al. Effect of localized cryotherapy on interdigital pruritus of dogs with canine atopic dermatitis. J Vet Sci 2025; 26: e43. 20250611. DOI: 10.4142/jvs.25049.
  • Dermocorticoïdes
    • Lorente-Mendez C and Alonso-Miguel D. Hydrocortisone Aceponate for Chronic Otitis: Long-Term Efficacy. Vet Dermatol 2025 20250804. DOI: 10.1111/vde.70008.
    • De Lucia M, Denti D, Werlen NA, et al. Canine pigmented viral plaques associated with application of potent topical glucocorticoids. Vet Dermatol 2025; 36: 104–108. 20240910. DOI: 10.1111/vde.13298.
  • Greffe de microbiote
    • Ural K, Erdoğan H, Erdoğan S, et al. Heterologue Skin Microbiota Transplantation in Dogs with Primary and Secondary Dermatoses: Large Prospective Cohort Study. Journal of Health Sciences Institute 2025:10(2):148-157 2025; 10: 148–157.
  • Immunothérapie allergénique
    • Morales-Romero R, Gonzalez-Dominguez MS, Sanchez J, et al. Efficacy of diagnostic testing for allergen sensitization in canine atopic dermatitis: a systematic review. Front Vet Sci 2025; 12: 1551207. 20250521. DOI: 10.3389/fvets.2025.1551207.
    • Haidamak AM. Dynamics of clinical parameters in dogs with atopic dermatitis during allergen-specific immunotherapy with glutaraldehyde-polymerized allergoid. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies Series: Veterinary Sciences 2025; 27: 50–55. DOI: 10.32718/nvlvet12006.
    • Reinbacher E, Wagner R and Müller E. Die Allergen-spezifische Immuntherapie (ASIT) bei Hunden mit atopischer Dermatitis - Was sind die Gründe für einen Behandlungsabbruch und wie kan der Behandlungserfolg optimiert werden? Kleintierpraxis 2025; 70: 236–246.
    • Bizikova P, Matsumoto C, Ogino S, et al. Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study. Veterinary Dermatology 2025; n/a. DOI: https://doi.org/10.1111/vde.70037.
    • Welters M, Mas-Fontao A, Auxilia ST, et al. Composition Heterogeneity and Low-Molecular-Weight Allergen Content of Dermatophagoides farinae House Dust Mite Allergen Extracts Used in Veterinary Medicine. Vet Sci 2025; 12 20250827. DOI: 10.3390/vetsci12090824.
    • Vinberg C, Åhman S, Cikota R, et al. Owners’ overall satisfaction with alum-precipitated subcutaneous allergen-specific immunotherapy and factors contributing to premature discontinuation in a large cohort of 407 dogs. In: 35th European Veterinary Dermatology Congress Bilbao, 2025, p.216.
    • Nagata M, Kozakai J, Yoshida A, et al. Immunotherapy using pullulan-conjugated Der f 2 allergen in canine atopic dermatitis: An anti-inflammatory agent-sparing approach. Vet Dermatol 2025 20241217. DOI: 10.1111/vde.13315.
  • JAKi
    • Boerngen K, Patel Y, Pittorino M, et al. Pharmacokinetics of Ilunocitinib, a New Janus Kinase Inhibitor, in Dogs. J Vet Pharmacol Ther 2025 20250908. DOI: 10.1111/jvp.70022.
    • Bachtel JC and Snidow M. Efficacy of Combination Oclacitinib and Lokivetmab Therapies After Monotherapeutic Failure in 44 Dogs: A Retrospective Study. Vet Dermatol 2025 20251104. DOI: 10.1111/vde.70034.
    • Fent GM, Despa S, Gabor L, et al. Response to primary canine core vaccination in 10-month-old seronegative dogs treated with three times the recommended therapeutic dose of Ilunocitinib tablets (Zenrelia). BMC Vet Res 2025; 21: 461. 20250714. DOI: 10.1186/s12917-025-04896-5.
    • Fent GM, Jacela J, Plazola-Ortiz R, et al. Immunologic response to first booster vaccination in dogs treated with zenrelia (ilunocitinib tablets) at up to three times the recommended therapeutic dose compared to untreated controls. BMC Vet Res 2025; 21: 481. 20250722. DOI: 10.1186/s12917-025-04929-z.
    • Lister S, Basile JK and Wegenast C. Oclacitinib Intoxication. J Vet Emerg Crit Care (San Antonio) 2025; 35: 176–177. 20250420. DOI: 10.1111/vec.13459.
    • Forster S, Trout CM, Despa S, et al. Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client-owned dogs: A multicentre, double-masked, randomised, placebo-controlled clinical trial. Vet Dermatol 2025 20250429. DOI: 10.1111/vde.13344.
    • Popp P and Müller R. Evaluation of the induction protocol for oclacitinib in dogs. Tierarztl Prax Ausg K Kleintiere Heimtiere 2025: P21. DOI: 10.1055/s-0045-1802619.
    • Kuntz EA, Gabor L and Toutain CE. Safety of ilunocitinib tablets (Zenrelia) after once daily oral administration in dogs. BMC Vet Res 2025; 21: 144. 20250305. DOI: 10.1186/s12917-025-04579-1.
    • Zhang TY and Zeng YP. Off-label use of JAK1 inhibitor upadacitinib in dermatology. Arch Dermatol Res 2025; 317: 363. 20250207. DOI: 10.1007/s00403-025-03890-z.
    • Villalobos WR, Ferreira T, Borek F, et al. Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration. Vet Dermatol 2025 20250305. DOI: 10.1111/vde.13334.
    • Nederveld SM, Krautmann MJ and Mitchell J. Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs. J Vet Pharmacol Ther 2025 20250228. DOI: 10.1111/jvp.13503.
    • Ferreira TS, Villalobos WR, Gmyterco VC, et al. Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial. Vet Dermatol 2025 20250203. DOI: 10.1111/vde.13327.
    • Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Vet Dermatol 2025; 36: 165–176. 20250106. DOI: 10.1111/vde.13319.
    • Čonková E, Váczi P and Malinovská Z. Antifungal Efficacy of Selected Plant Essential Oils Against Clinical Canine Isolates Malassezia pachydermatis. Microorganisms 13: 2675. DOI: 10.3390/microorganisms13122675.
    • Kim Y, Seo G, Koopman JJE, et al. Real-World Effectiveness and Safety of JAK Inhibitors in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Clin Exp Allergy 2025; 55: 755–772. 20250802. DOI: 10.1111/cea.70125.
  • Methotrexate
    • Meyer L. Évaluation de l'intérêt du méthotrexate utilisé à faible dose pour le traitement de la dermatite atopique modérée à sévère chez le chien. ONIRIS, 2025.
    • Mosca M, Rostang A, Panzuti P, et al. A prospective, double-blinded, noninferiority randomized clinical trial comparing the efficacy and safety of methotrexate and ciclosporin for the control of canine atopic dermatitis. In: 35th European Veterinary Dermatology Congress (ed ESVD-ECVD-ISVD), Bilbao, 2025, p.179.
  • Biothérapies
    • Wang J, Zhou X, Elazab ST, et al. Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine. Animals (Basel) 2025; 15 20250207. DOI: 10.3390/ani15040472.
    • Gober M, Amodie D, Mellencamp M, et al. Long term use of lokivetmab (Cytopoint(R)) in atopic dogs. BMC Vet Res 2025; 21: 203. 20250326. DOI: 10.1186/s12917-025-04645-8.
  • Nouvlles molécules
    • Ahn JH, Kim J, Kwak J, et al. JAK-STAT inhibitory effect of IN-115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine. Br J Pharmacol 2025; 182: 5071–5082. 20250507. DOI: 10.1111/bph.70055.
    • Song Y, Kim S, Mukhopadhyay S, et al. Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa. Pharmaceutics 2025; 17 20251014. DOI: 10.3390/pharmaceutics17101332.
  • Plasma froid
    • Mueller RS and Bouassiba C. Single Cold Atmospheric Plasma Therapy May Improve the Treatment Outcome of Canine Otitis Externa With Secondary Infection. Vet Dermatol 2025 20250910. DOI: 10.1111/vde.70027.
  • Probiotiques
    • Bonel-Ayuso DP, Pineda-Pampliega J, Martinez-Aleson Garcia P, et al. Effects of Postbiotic Administration on Canine Health: A Systematic Review and Meta-Analysis. Microorganisms 2025; 13 20250703. DOI: 10.3390/microorganisms13071572.
    • Lagoa T, Martins L and Queiroga MC. Microbiota Modulation as an Approach to Prevent the Use of Antimicrobials Associated with Canine Atopic Dermatitis. Biomedicines 2025; 13 20250927. DOI: 10.3390/biomedicines13102372.
    • Huang HW, Yeh TC, Hsieh JC, et al. Evaluating the Adjuvant Therapeutic Effects of Probiotic Strains Lactococcus cremoris and Lacticaseibacillus paracasei on Canine Atopic Dermatitis and Their Impact on the Gut and Skin Microbiome. Animals (Basel) 2025; 15 20251024. DOI: 10.3390/ani15213098.
    • Pacheco RCF, Lins LF, de Brito LP, et al. Probiotics as an adjunct in the treatment of canine atopic dermatitis: a systematic review and meta-analysis of in vivo studies in dogs. J Vet Med Sci 2025 20250701. DOI: 10.1292/jvms.24-0471.
    • Song H, Mun SH, Han DW, et al. Probiotics ameliorate atopic dermatitis by modulating the dysbiosis of the gut microbiota in dogs. BMC Microbiol 2025; 25: 228. 20250422. DOI: 10.1186/s12866-025-03924-6.
    • Loeffler A, Cain CL, Ferrer L, et al. Synopsis of the antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Vet Dermatol 2025 20250624. DOI: 10.1111/vde.13365.
  • Pyodermites
    • Loeffler A, Cain CL, Ferrer L, et al. Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Vet Dermatol 2025; 36: 234–282. DOI: 10.1111/vde.13342.
    • Gmyterco VC, Luciano FB, Ludwig LA, et al. Comparative study of a commercial formula containing natural antimicrobials versus oral cephalexin or topical chlorhexidine-miconazole therapies for treating superficial pyoderma in dogs. Vet Dermatol 2025 20250108. DOI: 10.1111/vde.13323.
  • Topiques
    • Prescott D, Stewart A, Schoep A, et al. Topical cream with essential oils, zinc and salicylic acid reduces pruritus and skin lesion scores in pruritic dogs. Aust Vet J 2025 20251208. DOI: 10.1111/avj.70048.
    • Pseftogka A, Samuel Badulescu E, Chatzis MK, et al. Effect of a Spray Containing Occlusive Agents, Humectants and Physiological Lipids on Skin Hydration of Healthy Dogs When Applied After Bathing With a Chlorhexidine 2%/Miconazole 2% Shampoo. Vet Dermatol 2025 20250901. DOI: 10.1111/vde.70025.
  • Qualité de vie
    • Rhodius PC, Fischer N, Rostaher A, et al. Development of a Four-Language Questionnaire to Investigate Environmental Risk Factors for the Development of Canine Atopic Dermatitis and to Monitor Disease Course and Progression. Vet Dermatol 2025 20250901. DOI: 10.1111/vde.70024.
    • Dembele V, McHale M, Ortalda C, et al. A prospective study evaluating the impact of chronic otitis on the quality-of-life of dogs and their owners and assessment of the short-term impact of specialist intervention. Vet Dermatol 2025 20250509. DOI: 10.1111/vde.13347.
    • Birner VA and Mueller RS. [Canine atopic dermatitis - Special consideration of caregiver burden and quality of life of affected dogs and owners]. Tierarztl Prax Ausg K Kleintiere Heimtiere 2025; 53: 338–349. 20251128. DOI: 10.1055/a-2712-9246.
    • Wright A, Gildea E, Greaves M, et al. Exploring Pet Owner Preferences in Order to Assess the Role of Cost and Quality of Life in Anti-Pruritic Treatment Plan Selection for Dog Owners. Animals (Basel) 2025; 15 20250211. DOI: 10.3390/ani15040509.

*principales sources : PubMed et Google Scholar